Evidence map›Paper›PMID 31328582›Full record

ReviewExpert opinion on drug delivery2019

Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment.

Yuqing Gong, Pallabita Chowdhury, Prashanth K B Nagesh, Theodore J Cory, Chelsea Dezfuli, Sunitha Kodidela, Ajay Singh, Murali M Yallapu, Santosh Kumar

Open access · greenAbstract readReview
In one paragraph

Review in Expert opinion on drug delivery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. The Promise of Nanotechnology in Personalized Medicine.Journal of personalized medicine · 2022
    Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuqing Gonga Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Pallabita Chowdhurya Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Prashanth K B Nagesha Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Theodore J Coryb Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Chelsea Dezfulib Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Sunitha Kodidelaa Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Ajay Singha Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Murali M Yallapua Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
Santosh Kumara Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center , Memphis , TN , USA.
University of Tennessee Health Science Center · US

Funding

Monocytic and exosomal cytochrome P450s in smoking-mediated HIV-1 pathogenesisR01DA047178 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CORY, THEODORE, KUMAR, SANTOSH · 2018 to 2022
$1.7M
Role of cytochrome P450 in alcohol-mediated effects on antiretroviral and HIV-1R01AA022063 · NIAAA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KUMAR, SANTOSH · 2013 to 2017
$1.7M
PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer TherapyK22CA174841 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI YALLAPU, MURALI MOHAN · 2015 to 2017
$485k
Targeted Nano-Chemosensitization of Breast CancersR15CA213232 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KUMAR, SANTOSH · 2017 to 2017
$440k
NCI NIH HHS K22 CA174841NCI NIH HHS R15 CA213232NIAAA NIH HHS R01 AA022063NIDA NIH HHS R01 DA047178
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-HIV AgentsCytochrome P-450 Enzyme SystemDosage FormsHIV-1HIV InfectionsHumansNanotechnologyAnti-HIV AgentsCytochrome P-450 Enzyme SystemDosage FormsAntiretroviral drugsCYP substratesHIVnanotechnology

Identifiers

PMID31328582
PMCPMC7183141
OpenAlexW2964269394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.